Trial Profile
Clinical Trials Insight: 700031420
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2008
Price :
$35
*
At a glance
- Drugs Melanoma DNA vaccine (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Oxxon Therapeutics
- 11 Mar 2008 New trial record.